BR112016005413A8 - Usos de pelo menos um mirna, kit, métodos de diagnóstico de câncer de mama e métodos para avaliação de risco de metástase - Google Patents

Usos de pelo menos um mirna, kit, métodos de diagnóstico de câncer de mama e métodos para avaliação de risco de metástase

Info

Publication number
BR112016005413A8
BR112016005413A8 BR112016005413A BR112016005413A BR112016005413A8 BR 112016005413 A8 BR112016005413 A8 BR 112016005413A8 BR 112016005413 A BR112016005413 A BR 112016005413A BR 112016005413 A BR112016005413 A BR 112016005413A BR 112016005413 A8 BR112016005413 A8 BR 112016005413A8
Authority
BR
Brazil
Prior art keywords
methods
breast cancer
mirna
kit
risk assessment
Prior art date
Application number
BR112016005413A
Other languages
English (en)
Other versions
BR112016005413A2 (pt
Inventor
Maria Chiquitelli Marques Silveira Márcia
Aloisio Da Costa Vieira René
Longatto Filho Adhemar
Ludvik Filip Marino Augusto
Feijo Evangelista Adriane
Cesar Santejo Silveira Henrique
Macedo Taciane
Maria Kerr Ligia
Original Assignee
Fund De Amparo A Pesquisa Do Estado De Sao Paulo
Fund Pio Xii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund De Amparo A Pesquisa Do Estado De Sao Paulo, Fund Pio Xii filed Critical Fund De Amparo A Pesquisa Do Estado De Sao Paulo
Publication of BR112016005413A2 publication Critical patent/BR112016005413A2/pt
Publication of BR112016005413A8 publication Critical patent/BR112016005413A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)

Abstract

USOS DE PELO MENOS UM miRNA, KIT, MÉTODOS DE DIAGNÓSTICO DE CÂNCER DE MAMA E MÉTODOS PARA AVALIAÇÃO DE RISCOS DE METÁSTASE. A presente invenção refere-se a novos usos de pelo menos um microRNAs, como biomarcadores de câncer de mama e como biomarcadores de potencial metastático em câncer de mama. Ainda, a presente invenção refere-se a kits que compreendem ditos biomarcadores e aos métodos de diagnóstico de câncer de mama e para avaliação de risco de metástase.
BR112016005413A 2013-09-11 2013-09-11 Usos de pelo menos um mirna, kit, métodos de diagnóstico de câncer de mama e métodos para avaliação de risco de metástase BR112016005413A8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2013/000357 WO2015035480A1 (pt) 2013-09-11 2013-09-11 USOS DE PELO MENOS UM miRNA, KIT, MÉTODOS DE DIAGNÓSTICO DE CÂNCER DE MAMA E MÉTODOS PARA AVALIAÇÃO DE RISCO DE METÁSTASE

Publications (2)

Publication Number Publication Date
BR112016005413A2 BR112016005413A2 (pt) 2017-11-21
BR112016005413A8 true BR112016005413A8 (pt) 2018-04-03

Family

ID=52664853

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016005413A BR112016005413A8 (pt) 2013-09-11 2013-09-11 Usos de pelo menos um mirna, kit, métodos de diagnóstico de câncer de mama e métodos para avaliação de risco de metástase

Country Status (2)

Country Link
BR (1) BR112016005413A8 (pt)
WO (1) WO2015035480A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110184351A (zh) * 2019-05-29 2019-08-30 南通普惠精准医疗科技有限公司 检测试剂盒的应用
WO2023170659A1 (en) 2022-03-11 2023-09-14 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) Breast cancer diagnostic and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007016548A2 (en) * 2005-08-01 2007-02-08 The Ohio State University Research Foundation Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
EP2280078B1 (en) * 2008-03-27 2016-05-18 Kuroda, Masahiko Marker for determination of breast cancer, test method, and test kit

Also Published As

Publication number Publication date
BR112016005413A2 (pt) 2017-11-21
WO2015035480A1 (pt) 2015-03-19

Similar Documents

Publication Publication Date Title
HK1226482B (zh) 胰腺癌用唾液生物標記物以及使用了胰腺癌用唾液生物標記物的胰腺癌的診斷方法
BR112013004673A2 (pt) biomarcadores e métodos de tratamento.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
DK3435084T3 (da) Prostatakræftprognose under anvendelse af biomarkører
MX2017010836A (es) Panel biomarcador para la deteccion de cancer.
BR112013029787A2 (pt) biomarcadores para câncer de pulmão
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
EP2971132A4 (en) FABRIC AND BLOOD-BASED MIRNA BIOMARKERS FOR THE DIAGNOSIS, FORECASTING AND PREDICTING THE METASTAS POTENTIAL IN COLOR LECTAL CANCER
MX2016012285A (es) Tratamiento de cáncer con antagonista de c-met y correlación de estos con la expresión de hgf.
BR112017016808A2 (pt) biomarcadores para câncer pancreático
BR112017028287A2 (pt) Combinação do inibidor hdac e anticorpido anti-pd- l1 para o tratamento do câncer
MX2015010174A (es) Herramientas de diagnostico para predecir la presentacion de preeclampsia.
TR201909951T4 (tr) Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.
TR201911039T4 (tr) Ptp1b ile ilişkili bir hastalığın tedavisine yönelik aminosteroidler.
WO2013186639A3 (en) Methylation biomarkers for breast cancer
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
UY36223A (es) Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
GB201322800D0 (en) Prostate cancer biomarkers
BR112016013976A2 (pt) método para determinar se um indivíduo é afetado por um câncer, método para discriminar entre câncer colorretal e pancreático dentre indivíduos que resultam ser positivos para o método, método para determinar o estágio de um câncer colorretal em um indivíduo afetado e uso de um kit de rt-pcr quantitativo para performar o método
DK3004875T3 (da) Prædiktiv biomarkør til cancerterapi
WO2014187884A3 (en) Mirnas as non-invasive biomarkers for heart failure
IL244632A0 (en) Cancer biomarker and diagnostics
MX2015015015A (es) Metodo para diagnosticar cancer.
EA201590495A1 (ru) Способ диагностики и лечения рака, направленный на молекулы, экспрессируемые в раковых стволовых клетках

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: FUNDACAO PIO XII (BR/SP) , FUNDACAO DE AMPARO A PE

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements